EV/EBITDA
12.77
+0.03+0.24%
1 min ago
Summary:
Halozyme Therapeutics EV/EBITDA is currently 12.77, with a rise of +0.03 (+0.24%) during the most recent trading day. Over the past year, it has dropped by -2.47 (-16.21%). HALO EV/EBITDA is now -99.60% below its all-time high of 3163.18.HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.2% |
| 1 m1 month | -0.2% |
| 3 m3 months | -22.2% |
| 6 m6 months | -17.8% |
| ytdytd | -4.8% |
| 1 y1 year | -16.2% |
| 5 y5 years | +111.6% |
HALO EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 13.28 | -3.8% | 12.46 | +2.5% |
| 3 m | 3 months | 16.41 | -22.2% | 11.70 | +9.2% |
| 6 m | 6 months | 18.37 | -30.5% | 11.70 | +9.2% |
| 1 y | 1 year | 18.37 | -30.5% | 11.70 | +9.2% |
| 3 y | 3 years | 32.43 | -60.6% | 11.70 | +9.2% |
| 5 y | 5 years | 140.85 | -90.9% | -218.09 | +105.9% |
| alltime | all time | 3163.18 | -99.6% | -218.09 | +105.9% |
Halozyme Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 12.77(-4.8%) |
| 2023 | 13.42(-52.7%) |
| 2022 | 28.36(+16.9%) |
| 2021 | 24.27(-38.3%) |
| 2020 | 39.33(-182.2%) |
| 2019 | -47.85(+30.0%) |
| 2018 | -36.82(-207.9%) |
| 2017 | 34.13(-289.8%) |
| 2016 | -17.98(-79.5%) |
| 2015 | -87.86(+346.2%) |
| Date | Value |
|---|---|
| 2014 | -19.69(-10.6%) |
| 2013 | -22.02(+68.0%) |
| 2012 | -13.11(-73.8%) |
| 2011 | -50.13(+270.8%) |
| 2010 | -13.52(+63.7%) |
| 2009 | -8.26(+4.0%) |
| 2008 | -7.94(-52.0%) |
| 2007 | -16.55(-50.1%) |
| 2006 | -33.19(+389.5%) |
| 2005 | -6.78(-34.1%) |
| 2004 | -10.29 |
FAQ
- What is Halozyme Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Halozyme Therapeutics?
- What is HALO EV/EBITDA year-to-date change?
- What is Halozyme Therapeutics EV/EBITDA year-on-year change?
What is Halozyme Therapeutics EV/EBITDA?
The current EV/EBITDA of HALO is 12.77
What is the all time high EV/EBITDA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high EV/EBITDA is 3163.18
What is HALO EV/EBITDA year-to-date change?
Halozyme Therapeutics EV/EBITDA has changed by -0.65 (-4.84%) since the beginning of the year
What is Halozyme Therapeutics EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -2.47 (-16.21%)